Non-small cell lung cancer: how do experts want to be treated?

N. Aksel (Izmir, Turkey), B. Aktin Yoldas (Izmir, Turkey), E. Kirakli (Izmir, Turkey), I. Petekkaya (Izmir, Turkey)

Source: Virtual Congress 2021 – COVID-19 and management of lung cancer
Session: COVID-19 and management of lung cancer
Session type: E-poster
Number: 3852

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
N. Aksel (Izmir, Turkey), B. Aktin Yoldas (Izmir, Turkey), E. Kirakli (Izmir, Turkey), I. Petekkaya (Izmir, Turkey). Non-small cell lung cancer: how do experts want to be treated?. 3852

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Surgery for elderly early-stage non-small cell lung cancer: less or more?
Source: International Congress 2019 – All aspects of general thoracic surgery
Year: 2019



Metastatic disease in non-small cell lung cancer: is it all the same?
Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up
Year: 2017

Non-small cell lung cancer in never-smokers
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016


Non-small cell lung cancer with single brain metastasis: the role of surgical treatment
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008

Second-line medical treatment for nonsmall cell lung cancer: what happens in reality
Source: Annual Congress 2010 - Lung cancer progress after first-line therapy: which treatment makes sense and which does not?
Year: 2010


Stem cells and lung cancer treatment: any hope?
Source: International Congress 2016 – Molecular footprints in lung cancer diagnosis and management
Year: 2016


Nonsmall cell lung cancer
Source: Annual Congress 2012 - Maurizio Vignola Award for Innovation in Pneumology Ceremony (supported by Chiesi Foundation) followed by Clinical Year in Review I
Year: 2012


Lung cancer: does age affect treatment strategy?
Source: Eur Respir Mon; 2009: 43:306–326
Year: 2009

Response to Immunotherapy in non-small cell lung cancer: the effect of weight
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


Treatment of  non-small cell lung cancer (NSCLC) - the state of the art and beyond
Source: International Congress 2017 – State of the art session: "Lung cancer"
Year: 2017


Personalised medicine for nonsmall cell lung cancer
Source: Eur Respir Rev, 26 (146) 170066; 10.1183/16000617.0066-2017
Year: 2017



Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Source: ERS webinar 2021: Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
Year: 2021


Advanced non-small cell lung cancer in elderly patients
Source: Breathe 2012; 9: 26-34
Year: 2012

Update on nonsmall cell lung cancer
Source: Eur Respir Rev 2010 19: 173-185
Year: 2010


New treatment options for nonsmall cell lung cancer and small cell lung cancer
Source: Annual Congress 2006 - PG12 - Small cell lung cancer management
Year: 2006

Customising chemotherapy in advanced nonsmall cell lung cancer: daily practice and perspectives
Source: Eur Respir Rev 2011; 20: 45-52
Year: 2011